Summary
- Current Price
- As of today, ENGN price is $1.50, down -12.79% on
- Current Price All-Time High
- ENGN price is currently -96.82% below its historical high of $47.17 set on
- Market Cap
- ENGN current market cap is $100M, down -41.96% year-over-year
- PE Ratio
- ENGN PE ratio is unknown
- Revenue
- ENGN current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ENGN has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | enGene Therapeutics Inc. |
| Ticker | NASDAQ: ENGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | engene.com |
| Employees | 81 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1.50 | |
| Price, 1D Change | -12.79% | |
| $100M | ||
| - | ||
| - | ||
| 1.86 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.29 | ||
| EPS, 1Y Change | -57.23% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.29 | ||
| EPS Estimate | N/A | -$1.97 |
| EPS Est. Change | N/A | +13.98% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $1.50 | |
| Price Target | - | $25.00 |
| Price Tgt. Change | - | +1,566.67% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.39 | -$1.46 | -5.23% | |
| -$2.10 | -$2.29 | -9.16% | |
| -$1.97 | N/A | +13.98% | |
| -$1.90 | N/A | +17.23% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $26.28M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $1.50 | |
| $7.41 | ||
| SMA 200 vs Price | +394.10% | |
| $7.39 | ||
| SMA 50 vs Price | +392.87% | |
| 1.86 | ||
| $1.02 | ||
| 21.87 | ||
| 419.83% | ||
| 123.96% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.29 | ||
| -$509.00K | ||
| - | ||
| -$123.17M | ||
| - | ||
| -$117.30M | ||
| - | ||
| -$122.66M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.19 | ||
| 6.30 | ||
| 6.30 | ||
| - | ||
| - | ||
| -2.15 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.36 | ||
| 1.12 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $167.71M | ||
| $193.82M | ||
| $221.47M | ||
| $201.39M | ||
| $53.76M | ||
| $31.98M | ||
| $31.80M | ||
| $10.02M | ||
| $6.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $117.30M | ||
| $122.66M | ||
| $509.00K | ||
| $0.00 | ||
| $509.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$99.24M | ||
| -$25.14M | ||
| $1.52M | ||
| $1.49M | ||
| -$100.72M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Citizens | → | |
| WBB Securities | ||
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| Oppenheimer | → |
Analyst sentiment
Institutional ownership
Screeners with ENGN
FAQ
What is the ticker symbol for enGene Therapeutics Inc.?
The ticker symbol for enGene Therapeutics Inc. is NASDAQ:ENGN
Does enGene Therapeutics Inc. pay dividends?
No, enGene Therapeutics Inc. does not pay dividends
What sector is enGene Therapeutics Inc. in?
enGene Therapeutics Inc. is in the Healthcare sector
What industry is enGene Therapeutics Inc. in?
enGene Therapeutics Inc. is in the Biotechnology industry
What country is enGene Therapeutics Inc. based in?
enGene Therapeutics Inc. is headquartered in Canada
When did enGene Therapeutics Inc. go public?
enGene Therapeutics Inc. initial public offering (IPO) was on February 1, 2022
Is enGene Therapeutics Inc. in the S&P 500?
No, enGene Therapeutics Inc. is not included in the S&P 500 index
Is enGene Therapeutics Inc. in the NASDAQ 100?
No, enGene Therapeutics Inc. is not included in the NASDAQ 100 index
Is enGene Therapeutics Inc. in the Dow Jones?
No, enGene Therapeutics Inc. is not included in the Dow Jones index
When was enGene Therapeutics Inc. last earnings report?
enGene Therapeutics Inc.'s most recent earnings report was on September 10, 2025
When does enGene Therapeutics Inc. report earnings?
The date for enGene Therapeutics Inc.'s next earnings report has not been announced yet
Data Sources & References
- ENGN Official Website www.engene.com
- ENGN Profile on Yahoo Finance finance.yahoo.com/quote/ENGN
- ENGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/engn